136 Antiviral effect of BILN 2061, a novel HCV serine protease inhibitor, after oral treatment over 2 days in patients with chronic hepatitis C, non-genotype 1

Hepatology ◽  
2003 ◽  
Vol 38 ◽  
pp. 221-221 ◽  
Author(s):  
M REISER ◽  
H HINRICHSEN ◽  
Y BENHAMOU ◽  
R SENTJENS ◽  
H WEDEMEYER ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Protease Inhibitor ◽  
Serine Protease ◽  
Chronic Hepatitis C ◽  
Oral Treatment ◽  
Antiviral Effect ◽  
Serine Protease Inhibitor ◽  
Genotype 1

Danoprevir, an HCV NS3/4A protease inhibitor, improves insulin sensitivity in patients with genotype 1 chronic hepatitis C

Gut ◽  
2010 ◽  
Vol 59 (12) ◽  
pp. 1694-1698 ◽  
Author(s):  
Rami Moucari ◽  
Nicole Forestier ◽  
Dominique Larrey ◽  
Dominique Guyader ◽  
Patrice Couzigou ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Insulin Sensitivity ◽  
Protease Inhibitor ◽  
Chronic Hepatitis C ◽  
Genotype 1
Sign in / Sign up

Export Citation Format

Share Document